12.34% of Petros Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Petros Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/26/2024	Virtu Financial LLC	24,825	$35K	0.0%	N/A	1.128%
8/14/2023	Schonfeld Strategic Advisors LLC	23,200	$47K	0.0%	N/A	1.110%
8/11/2023	Renaissance Technologies LLC	16,779	$34K	0.0%	N/A	0.803%
8/2/2023	Bank of Montreal Can	10,000	$27K	0.0%	N/A	0.478%
11/15/2022	Vanguard Group Inc.	255,914	$0.13M	0.0%	+114.8%	1.236%
8/13/2022	Virtu Financial LLC	53,594	$44K	0.0%	N/A	0.259%
5/13/2022	Vanguard Group Inc.	113,823	$0.18M	0.0%	-24.7%	0.550%
5/12/2022	BlackRock Inc.	191,715	$0.30M	0.0%	+880.2%	0.927%
1/27/2022	Emfo LLC	10,000	$33K	0.0%	-64.3%	0.048%
11/12/2021	NorthRock Partners LLC	115,295	$0.43M	0.0%	-47.4%	1.173%
9/17/2021	Virtu Financial LLC	14,364	$45K	0.0%	N/A	0.146%
8/16/2021	Shay Capital LLC	238,764	$0.75M	0.1%	-7.0%	2.437%
8/13/2021	Renaissance Technologies LLC	54,887	$0.17M	0.0%	-70.4%	0.560%
8/13/2021	Geode Capital Management LLC	23,725	$74K	0.0%	+67.3%	0.242%
8/13/2021	Vanguard Group Inc.	107,500	$0.34M	0.0%	+21.2%	1.097%
8/12/2021	NorthRock Partners LLC	219,188	$0.69M	0.1%	-35.1%	2.237%
8/10/2021	CM Management LLC	100,000	$0.31M	0.2%	+122.2%	1.021%
8/5/2021	Platform Technology Partners	44,000	$0.14M	0.1%	N/A	0.449%
5/21/2021	Citadel Advisors LLC	35,492	$0.13M	0.0%	N/A	0.362%
5/18/2021	Citadel Advisors LLC	35,492	$0.13M	0.0%	N/A	0.363%
5/13/2021	Renaissance Technologies LLC	185,545	$0.69M	0.0%	+29.5%	1.900%
5/12/2021	Geode Capital Management LLC	14,180	$52K	0.0%	N/A	0.145%
5/11/2021	NorthRock Partners LLC	337,531	$1.26M	0.1%	-12.3%	3.455%
5/7/2021	BlackRock Inc.	18,277	$68K	0.0%	+35.1%	0.187%
4/12/2021	FNY Investment Advisers LLC	20,000	$73K	0.0%	N/A	0.205%
3/4/2021	Neville Rodie & Shaw Inc.	21,875	$96K	0.0%	N/A	0.224%
2/16/2021	One68 Global Capital LLC	24,883	$0.11M	0.2%	N/A	0.255%
2/11/2021	Cannell Peter B & Co. Inc.	25,484	$0.11M	0.0%	N/A	0.261%
2/10/2021	Renaissance Technologies LLC	143,247	$0.63M	0.0%	N/A	1.466%
2/8/2021	NorthRock Partners LLC	385,031	$1.69M	0.2%	N/A	3.942%
2/5/2021	BlackRock Inc.	13,531	$59K	0.0%	N/A	0.284%
2/5/2021	CM Management LLC	45,000	$0.20M	0.2%	N/A	0.946%
1/25/2021	Acorn Financial Advisory Services Inc. ADV	62,700	$0.28M	0.1%	N/A	1.318%

Data available starting January 2016

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, PreBoost, VenoSeal, penile injections, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.

Today's Range

Now: $0.70

$0.65

$0.73

50 Day Range

MA: $1.36

$0.69

$1.72

52 Week Range

Now: $0.70

$0.64

$9.54

Volume

229,783 shs

Average Volume

996,654 shs

Market Capitalization

$4.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad

Click here to find out that this 8,788% cryptocurrency is.